<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kim, June Myoung</style></author><author><style face="normal" font="default" size="100%">Choi, Eunju</style></author><author><style face="normal" font="default" size="100%">Lee, Kwanghyun</style></author><author><style face="normal" font="default" size="100%">Jung, Hak-Jun</style></author><author><style face="normal" font="default" size="100%">Shin, Hyun Soo</style></author><author><style face="normal" font="default" size="100%">Choih, Jenny</style></author><author><style face="normal" font="default" size="100%">Park, Heungrok</style></author><author><style face="normal" font="default" size="100%">Han, Sungho</style></author><author><style face="normal" font="default" size="100%">Bae, Donggoo</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">1173 GNUV205, a bifunctional protein of engineered IL-2 fused with a novel anti-PD1 antibody, exhibits superior tumor suppressing efficacy &lt;em&gt;in vivo&lt;/em&gt;
</style></title><secondary-title><style face="normal" font="default" size="100%">Journal for ImmunoTherapy of Cancer</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2023-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">A1293-A1293</style></pages><doi><style  face="normal" font="default" size="100%">10.1136/jitc-2023-SITC2023.1173</style></doi><volume><style face="normal" font="default" size="100%">11</style></volume><issue><style face="normal" font="default" size="100%">Suppl 1</style></issue><abstract><style  face="normal" font="default" size="100%">Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.</style></abstract></record></records></xml>